Guggenheim Remains Bullish Ahead of Teva Pharma's (TEVA) AGN Deal

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Guggenheim Remains Bullish Ahead of Teva Pharma's (TEVA) AGN Deal

Leerink Highlights Top 10 Biopharma Stocks for Partnerships & Acquisitions

April 14, 2016 12:07 PM EDT

In addition to naming Acadia Pharma (NASDAQ: ACAD) one of his top partnership and acquisition (P&A) targets, as noted earlier, Leerink analyst Joseph Schwartz listed 9 other stocks on his Top 10 list. Below is a run-down of the others:

Akorn, Inc. (NASDAQ: AKRX) (Market Perform)

Rationale for P&A: "AKRX operates in generic segments with higher barriers... More

Acadia Pharma (ACAD) Higher as Leerink Highlights as Partnership and Acquisition Target

April 14, 2016 9:57 AM EDT

Acadia Pharma (NASDAQ: ACAD) is solidly higher early Thursday (+3.2%) after Leerink Partners analyst Joseph Schwartz highlighted the company as one his Top Ten partnership and acquisition (P&A) stocks in biophama.

Commenting on the rationale for P&A, he said:

"Recent positive... More